Misidentification of dementia in Medicare claims is quite common.
Objective:
We examined potential race/ethnic disparities in misidentification of dementia in Medicare claims in a diverse cohort of older adults who underwent careful clinical assessment.
Methods:
Participants were enrolled in the Washington Heights-Inwood Columbia Aging Project (WHICAP), a multiethnic, population-based, prospective study of cognitive aging in which dementia status was assessed using a rigorous clinical protocol. ICD-9-CM and ICD-10-CM diagnosis codes in all available Medicare claims (1999–2019) were compared to clinical dementia diagnosis and categorized into three mutually exclusive groups: 1) congruent-, 2) over-, and 3) under- identification during the study period. Multinomial logistic regression model was used to examine the relationship between race (White, African American/Black, other) and ethnicity (Hispanic/Latinx, non-Hispanic/Latinx) and congruency of dementia identification after controlling for clinical (cognition, function, comorbidities) and demographic characteristics (age, sex, education), and inpatient and outpatient utilization.
Results:
Across all person-years, 88.4% had congruent identification of dementia compared to clinical diagnosis, in 4.1% of the times participants were over-identified with dementia, and 7.5% of the times the participants were under-identified. Rates of misidentification was higher in minority participants than in White, non-Hispanic participants. Multivariable estimation results showed that the probability of over-identification with dementia was 2.2% higher for African American/Black than White (p = 0.05) and 2.7% higher for Hispanic participants than non-Hispanics (p = 0.03) participants. Differences in under-identification by race/ethnicity were not statistically significant.
Conclusions:
African American/Black and Hispanic participants were more likely over-identified with dementia in Medicare claims.
BynumJ, LangaK (2020) Prevalence measurement for Alzheimer’s disease and dementia: Current status and future prospects. Paper Commissioned for a Workshop on Challenging Questions about Epidemiology, Care, and Caregiving for People with Alzheimer’s Disease and Related Dementias and Their Families. The National Academies Press, Washington DC.
2.
WilkinsonT, LyA, SchnierC, RannikmaeK, BushK, BrayneC, QuinnT, SudlowC, UK Biobank Neurodegenerative Outcomes Group and Dementias Platform UK (2018) Identifying dementia cases with routinely collected health data: A systematic review. Alzheimers Dement14, 1038–1051.
3.
HayesDJr, HigginsRS, BlackSM, WehrAM, LehmanAM, KirkbyS, WhitsonBA (2015) Effect of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis after lung transplantation: An analysis of the United Network of Organ Sharing registry. J Heart Lung Transplant34, 430–437.
4.
TaylorDHJr, OstbyeT, LangaKM, WeirD, PlassmanBL (2009) The accuracy of Medicare claims as an epidemiological tool: The case of dementia revisited. J Alzheimers Dis17, 807–815.
5.
LinPJ, KauferDI, MaciejewskiML, GangulyR, PaulJE, BiddleAK (2010) An examination of Alzheimer’s disease case definitions using Medicare claims and survey data. Alzheimers Dement6, 334–341.
6.
SavvaGM, ArthurA (2015) Who has undiagnosed dementia? A cross-sectional analysis of participants of the Aging, Demographics and Memory Study. Age Ageing44, 642–647.
7.
LangL, CliffordA, WeiL, ZhangD, LeungD, AugustineG, DanatIM, ZhouW, CopelandJR, AnsteyKJ, ChenR (2017) Prevalence and determinants of undetected dementia in the community: A systematic literature review and a meta-analysis. BMJ Open7, e011146.
8.
US Preventive Services Task Force, OwensDK, DavidsonKW, KristAH, BarryMJ, CabanaM, CaugheyAB, DoubeniCA, EplingJWJr, KubikM, LandefeldCS, MangioneCM, PbertL, SilversteinM, SimonMA, TsengCW, WongJB (2020) Screening for cognitive impairment in older adults: US Preventive Services Task Force Recommendation Statement. JAMA323, 757–763.
9.
ZhuCW, OrnsteinKA, CosentinoS, GuY, AndrewsH, SternY (2019) Misidentification of dementia in Medicare claims and related costs. J Am Geriatr Soc67, 269–276.
10.
ChinAL, NegashS, HamiltonR (2011) Diversity and disparity in dementia: The impact of ethnoracial differences in Alzheimer disease. Alzheimer Dis Assoc Disord25, 187–195.
11.
BabulalGM, QuirozYT, AlbensiBC, Arenaza-UrquijoE, AstellAJ, BabiloniC, Bahar-FuchsA, BellJ, BowmanGL, BrickmanAM, ChetelatG, CiroC, CohenAD, Dilworth-AndersonP, DodgeHH, DreuxS, EdlandS, EsbensenA, EveredL, EwersM, FargoKN, ForteaJ, GonzalezH, GustafsonDR, HeadE, HendrixJA, HoferSM, JohnsonLA, JuttenR, KilbornK, LanctotKL, ManlyJJ, MartinsRN, MielkeMM, MorrisMC, MurrayME, OhES, ParraMA, RissmanRA, RoeCM, SantosOA, ScarmeasN, SchneiderLS, SchupfN, SikkesS, SnyderHM, SohrabiHR, SternY, StrydomA, TangY, TerreraGM, TeunissenC, Melo van LentD, WeinbornM, WesselmanL, WilcockDM, ZetterbergH, O’BryantSE, International Society to Advance Alzheimer’s Research and Treatment, Alzheimer’s Association (2019) Perspectives on ethnic and racial disparities in Alzheimer’s disease and related dementias: Update and areas of immediate need. Alzheimers Dement15, 292–312.
BrewsterP, BarnesL, HaanM, JohnsonJK, ManlyJJ, NapolesAM, WhitmerRA, Carvajal-CarmonaL, EarlyD, FariasS, MayedaER, MelroseR, MeyerOL, Zeki Al HazzouriA, HintonL, MungasD (2019) Progress and future challenges in aging and diversity research in the United States. Alzheimers Dement15, 995–1003.
14.
AmjadH, RothDL, SheehanOC, LyketsosCG, WolffJL, SamusQM (2018) Underdiagnosis of dementia: An observational study of patterns in diagnosis and awareness in US older adults. J Gen Intern Med33, 1131–1138.
15.
ChenY, TysingerB, CrimminsE, ZissimopoulosJM (2019) Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims data. Alzheimers Dement (N Y)5, 197–207.
16.
GianattasioKZ, PratherC, GlymourMM, CiarleglioA, PowerMC (2019) Racial disparities and temporal trends in dementia misdiagnosis risk in the United States. Alzheimers Dement (N Y)5, 891–898.
17.
LennonJC, AitaSL, BeneVAD, RhoadsT, ReschZJ, EloiJM, WalkerKA (2022) Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation. Alzheimers Dement18, 1461–1471.
18.
MatthewsKA, XuW, GagliotiAH, HoltJB, CroftJB, MackD, McGuireLC (2019) Racial and ethnic estimates of Alzheimer’s disease and related dementias in the United States (2015-2060) in adults aged > /=65 years. Alzheimers Dement15, 17–24.
19.
ZhuY, ChenY, CrimminsEM, ZissimopoulosJM (2021) Sex, race, and age differences in prevalence of dementia in Medicare claims and survey data. J Gerontol B Psychol Sci Soc Sci76, 596–606.
LinPJ, DalyAT, OlchanskiN, CohenJT, NeumannPJ, FaulJD, FillitHM, FreundKM (2021) Dementia diagnosis disparities by race and ethnicity. Med Care59, 679–686.
22.
LinPJ, EmersonJ, FaulJD, CohenJT, NeumannPJ, FillitHM, DalyAT, MargaretosN, FreundKM (2020) Racial and ethnic differences in knowledge about one’s dementia status. J Am Geriatr Soc68, 1763–1770.
23.
TsoyE, KiekhoferRE, GutermanEL, TeeBL, WindonCC, DorsmanKA, LanataSC, RabinoviciGD, MillerBL, KindAJH, PossinKL (2021) Assessment of racial/ethnic disparities in timeliness and comprehensiveness of dementia diagnosis in California. JAMA Neurol78, 657–665.
24.
FroehlichTE, BogardusSTJr, InouyeSK (2001) Dementia and race: Are there differences between African Americans and Caucasians?J Am Geriatr Soc49, 477–484.
25.
US Census Bureau (2019) American Community Survey, 2013-2017 American Community Survey 5-Year Estimates, Selected Demographics, Social, Economic, Housing, and Demographic Characteristics, generated using American FactFinder; <http://factfinder.census.gov>, May 9, 2019.
26.
BradfordA, KunikME, SchulzP, WilliamsSP, SinghH (2009) Missed and delayed diagnosis of dementia in primary care: Prevalence and contributing factors. Alzheimer Dis Assoc Disord23, 306–314.
27.
SkinnerTR, ScottIA, MartinJH (2016) Diagnostic errors in older patients: A systematic review of incidence and potential causes in seven prevalent diseases. Int J Gen Med9, 137–146.
28.
TaylorDHJr, FillenbaumGG, EzellME (2002) The accuracy of Medicare claims data in identifying Alzheimer’s disease. J Clin Epidemiol55, 929–937.
29.
MayedaER, GlymourMM, QuesenberryCP, WhitmerRA (2016) Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Dement12, 216–224.
30.
FitzpatrickAL, KullerLH, IvesDG, LopezOL, JagustW, BreitnerJC, JonesB, LyketsosC, DulbergC (2004) Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc52, 195–204.
31.
ZuckermanIH, RyderPT, Simoni-WastilaL, ShafferT, SatoM, ZhaoL, StuartB (2008) Racial and ethnic disparities in the treatment of dementia among Medicare beneficiaries. J Gerontol B Psychol Sci Soc Sci63, S328–S333.
32.
ChenC, ZissimopoulosJM (2018) Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States. Alzheimers Dement (N Y)4, 510–520.
33.
ZhuCW, CosentinoS, OrnsteinK, GuY, AndrewsH, SternY (2015) Use and cost of hospitalization in dementia: Longitudinal results from a community-based study. Int J Geriatr Psychiatry30, 833–841.
34.
ZhuCW, CosentinoS, OrnsteinK, GuY, ScarmeasN, AndrewsH, SternY (2015) Medicare utilization and expenditures around incident dementia in a multiethnic cohort. J Gerontol A Biol Sci Med Sci70, 1448–1453.
EvansDA, BennettDA, WilsonRS, BieniasJL, MorrisMC, ScherrPA, HebertLE, AggarwalN, BeckettLA, JoglekarR, Berry-KravisE, SchneiderJ (2003) Incidence of Alzheimer disease in a biracial urban community: Relation to apolipoprotein E allele status. Arch Neurol60, 185–189.
37.
HaanMN, MungasDM, GonzalezHM, OrtizTA, AcharyaA, JagustWJ (2003) Prevalence of dementia in older latinos: The influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc51, 169–177.
38.
HallKS, GaoS, BaiyewuO, LaneKA, GurejeO, ShenJ, OgunniyiA, MurrellJR, UnverzagtFW, DickensJ, Smith-GambleV, HendrieHC (2009) Prevalence rates for dementia and Alzheimer’s disease in African Americans: 1992 versus 2001. Alzheimers Dement5, 227–233.
39.
NobleJM, SchupfN, ManlyJJ, AndrewsH, TangMX, MayeuxR (2017) Secular trends in the incidence of dementia in a multi-ethnic community. J Alzheimers Dis60, 1065–1075.
40.
Gilmore-BykovskyiAL, JinY, GleasonC, Flowers-BentonS, BlockLM, Dilworth-AndersonP, BarnesLL, ShahMN, ZuelsdorffM (2019) Recruitment and retention of underrepresented populations in Alzheimer’s disease research: A systematic review. Alzheimers Dement (N Y)5, 751–770.
41.
ScarmeasN, AlbertSM, ManlyJJ, SternY (2006) Education and rates of cognitive decline in incident Alzheimer’s disease. J Neurol Neurosurg Psychiatry77, 308–316.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944.
44.
SternY, AndrewsH, PittmanJ, SanoM, TatemichiT, LantiguaR, MayeuxR (1992) Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol49, 453–460.
45.
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th edn, American Psychiatric Association, Washington, DC.
BlessedG, TomlinsonBE, RothM (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry114, 797–811.
48.
ZhuCW, CosentinoS, OrnsteinKA, GuY, AndrewsH, SternY (2017) Interactive effects of dementia severity and comorbidities on Medicare expenditures. J Alzheimers Dis57, 305–315.
49.
QuanH, SundararajanV, HalfonP, FongA, BurnandB, LuthiJC, SaundersLD, BeckCA, FeasbyTE, GhaliWA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care43, 1130–1139.
